Castrate-resistant Prostate Cancer Market Size, Share & Trends Analysis Report By Therapy (Chemotherapy, Hormonal Therapy, Immunotherapy, Radiotherapy), By Region, And Segment Forecasts, 2025 - 2030

Castrate-resistant Prostate Cancer Market Size, Share & Trends Analysis Report By Therapy (Chemotherapy, Hormonal Therapy, Immunotherapy, Radiotherapy), By Region, And Segment Forecasts, 2025 - 2030


Public Safety And Security Market Growth & Trends

The global public safety and security market size is expected to reach USD 1,124.77 billion by 2030, expanding at a CAGR of 14.3% from 2025 to 2030, according to a new report by Grand View Research, Inc. The rapid modernization of public safety regulations and policies across the globe is anticipated to drive the market growth over the forecast period. These solutions have provided users with effective measures to ensure the safety of organizations, individuals, and critical infrastructure against multiple threats such as illegal immigration, terrorist attacks, and illegal drugs and arms trafficking. Furthermore, the rapidly increasing number of natural and man-made disasters is also expected to play a pivotal role in driving the demand for these solutions worldwide.

Over the past few years, an increasing collaboration among countries has been witnessed regarding the measures taken for public safety. Countries are hence focusing on establishing regional cooperation in the area of cross-border disaster management to address key issues by deploying emergency management systems, critical communication network infrastructure, and geospatial data collection and analysis tools, among others. Furthermore, developed as well as emerging economies around the world have realized the importance of public safety and security solutions in emergency and crisis management. Governments are now developing regulations and standards to improve surveillance and enhance public safety. Surveillance systems are particularly effective for transit agencies to monitor their systems remotely, while critical communication network enables secure communication between various units, which is crucial for crisis management.

Due to rapid digital transformation of global financial and banking systems, there has been a constant focus on deployment of digital security measures to deal with the increasing number of cyber-attacks. The increasing awareness regarding security systems, replacement of obsolete systems and technologies, and rise in hazardous industrial operations are also some of the major factors expected to drive the demand for these systems. Hence, to comply with the growing demand, there has been a significant increase in financial allocation by countries for upgrading and modernizing the existing information technology infrastructure and the setting-up of dedicated departments to deal with the emerging cyber threats. However, the high system acquisition and deployment costs and lack of interoperability between legacy and emerging security systems is hindering the growth of the public safety and security market.

Public Safety And Security Market Report Highlights
  • The critical communication network segment held the largest revenue share of 21.7% in 2024. Information and communication technology is vital in the seamless flow of businesses and governments.
  • The emergency & disaster management segment is expected to gain traction over the forecast period owing to the increasing need for these solutions for better management of natural calamities and emergency situations worldwide.
  • The logistics & transportation systems segment is expected to register the highest CAGR over the forecast period due to the increasing focus of governments on the development of road and rail infrastructure projects.
  • The Asia Pacific regional market is expected to grow at the highest CAGR from 2025 to 2030 owing to the increased spending on these solutions to improve public safety, particularly in emerging economies such as India and China.
Please note The report will be delivered in 2-3 business days upon order notification.


Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.2. Segment Definitions
1.2.1. Therapy
1.3. Estimates and Forecast Timeline
1.4. Research Methodology
1.5. Information Procurement
1.5.1. Purchased Database
1.5.2. GVR’s Internal Database
1.5.3. Secondary Sources
1.5.4. Primary Research
1.6. Information Analysis
1.6.1. Data Analysis Models
1.7. Market Formulation & Data Visualization
1.8. Model Details
1.8.1. Commodity Flow Analysis
1.9. List of Secondary Sources
1.10. Objectives
Chapter 2. Executive Summary
2.1. Market Snapshot
2.2. Segment Snapshot
2.3. Competitive Landscape Snapshot
Chapter 3. Castrate-resistant Prostate Cancer Market Variables, Trends, & Scope
3.1. Market Lineage Outlook
3.2. Market Dynamics
3.2.1. Market Driver Analysis
3.2.2. Market Restraint Analysis
3.3. Business Environment Analysis
3.3.1. Industry Analysis – Porter’s Five Forces Analysis
3.3.1.1. Supplier power
3.3.1.2. Buyer power
3.3.1.3. Substitution threat
3.3.1.4. Threat of new entrant
3.3.1.5. Competitive rivalry
3.3.2. PESTLE Analysis
Chapter 4. Castrate-resistant Prostate Cancer Market: Therapy Business Analysis
4.1. Therapy Market Share, 2024 & 2030
4.2. Therapy Segment Dashboard
4.3. Market Size & Forecasts and Trend Analysis, by Therapy, 2018 to 2030 (USD Million)
4.4. Chemotherapy
4.4.1. Chemotherapy market, 2018 - 2030 (USD Million)
4.5. Hormonal Therapy
4.5.1. Hormonal Therapy market, 2018 - 2030 (USD Million)
4.6. Immunotherapy
4.6.1. Immunotherapy market, 2018 - 2030 (USD Million)
4.7. Radiotherapy
4.7.1. Radiotherapy market, 2018 - 2030 (USD Million)
Chapter 5. Castrate-resistant Prostate Cancer Market: Region Estimates & Trend Analysis by Therapy
5.1. Region Market Share Analysis, 2024 & 2030
5.2. Region Market Dashboard
5.3. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
5.4. North America
5.4.1. North America castrate-resistant prostate cancer market estimates and forecasts, 2018 - 2030 (USD Million)
5.4.2. U.S.
5.4.2.1. Key country dynamics
5.4.2.2. Regulatory framework
5.4.2.3. Competitive insights
5.4.2.4. U.S. castrate-resistant prostate cancer market estimates and forecasts, 2018 - 2030 (USD Million)
5.4.3. Canada
5.4.3.1. Key country dynamics
5.4.3.2. Regulatory framework
5.4.3.3. Competitive insights
5.4.3.4. Canada castrate-resistant prostate cancer market estimates and forecasts, 2018 - 2030 (USD Million)
5.4.4. Mexico
5.4.4.1. Key country dynamics
5.4.4.2. Regulatory framework
5.4.4.3. Competitive insights
5.4.4.4. Mexico castrate-resistant prostate cancer market estimates and forecasts, 2018 - 2030 (USD Million)
5.5. Europe
5.5.1. Europe castrate-resistant prostate cancer market estimates and forecasts, 2018 - 2030 (USD Million)
5.5.2. UK
5.5.2.1. Key country dynamics
5.5.2.2. Regulatory framework
5.5.2.3. Competitive insights
5.5.2.4. UK castrate-resistant prostate cancer market estimates and forecasts, 2018 - 2030 (USD Million)
5.5.3. Germany
5.5.3.1. Key country dynamics
5.5.3.2. Regulatory framework
5.5.3.3. Competitive insights
5.5.3.4. Germany castrate-resistant prostate cancer market estimates and forecasts, 2018 - 2030 (USD Million)
5.5.4. France
5.5.4.1. Key country dynamics
5.5.4.2. Regulatory framework
5.5.4.3. Competitive insights
5.5.4.4. France castrate-resistant prostate cancer market estimates and forecasts, 2018 - 2030 (USD Million)
5.5.5. Italy
5.5.5.1. Key country dynamics
5.5.5.2. Regulatory framework
5.5.5.3. Competitive insights
5.5.5.4. Italy castrate-resistant prostate cancer market estimates and forecasts, 2018 - 2030 (USD Million)
5.5.6. Spain
5.5.6.1. Key country dynamics
5.5.6.2. Regulatory framework
5.5.6.3. Competitive insights
5.5.6.4. Spain castrate-resistant prostate cancer market estimates and forecasts, 2018 - 2030 (USD Million)
5.5.7. Norway
5.5.7.1. Key country dynamics
5.5.7.2. Regulatory framework
5.5.7.3. Competitive insights
5.5.7.4. Norway castrate-resistant prostate cancer market estimates and forecasts, 2018 - 2030 (USD Million)
5.5.8. Sweden
5.5.8.1. Key country dynamics
5.5.8.2. Regulatory framework
5.5.8.3. Competitive insights
5.5.8.4. Sweden castrate-resistant prostate cancer market estimates and forecasts, 2018 - 2030 (USD Million)
5.5.9. Denmark
5.5.9.1. Key country dynamics
5.5.9.2. Regulatory framework
5.5.9.3. Competitive insights
5.5.9.4. Denmark castrate-resistant prostate cancer market estimates and forecasts, 2018 - 2030 (USD Million)
5.6. Asia Pacific
5.6.1. Asia Pacific castrate-resistant prostate cancer market estimates and forecasts, 2018 - 2030 (USD Million)
5.6.2. Japan
5.6.2.1. Key country dynamics
5.6.2.2. Regulatory framework
5.6.2.3. Competitive insights
5.6.2.4. Japan castrate-resistant prostate cancer market estimates and forecasts, 2018 - 2030 (USD Million)
5.6.3. China
5.6.3.1. Key country dynamics
5.6.3.2. Regulatory framework
5.6.3.3. Competitive insights
5.6.3.4. China castrate-resistant prostate cancer market estimates and forecasts, 2018 - 2030 (USD Million)
5.6.4. India
5.6.4.1. Key country dynamics
5.6.4.2. Regulatory framework
5.6.4.3. Competitive insights
5.6.4.4. India castrate-resistant prostate cancer market estimates and forecasts, 2018 - 2030 (USD Million)
5.6.5. Thailand
5.6.5.1. Key country dynamics
5.6.5.2. Regulatory framework
5.6.5.3. Competitive insights
5.6.5.4. Thailand castrate-resistant prostate cancer market estimates and forecasts, 2018 - 2030 (USD Million)
5.6.6. South Korea
5.6.6.1. Key country dynamics
5.6.6.2. Regulatory framework
5.6.6.3. Competitive insights
5.6.6.4. South Korea castrate-resistant prostate cancer market estimates and forecasts, 2018 - 2030 (USD Million)
5.6.7. Australia
5.6.7.1. Key country dynamics
5.6.7.2. Regulatory framework
5.6.7.3. Competitive insights
5.6.7.4. Australia castrate-resistant prostate cancer market estimates and forecasts, 2018 - 2030 (USD Million)
5.7. Latin America
5.7.1. Latin America castrate-resistant prostate cancer market estimates and forecasts, 2018 - 2030 (USD Million)
5.7.2. Brazil
5.7.2.1. Key country dynamics
5.7.2.2. Regulatory framework
5.7.2.3. Competitive insights
5.7.2.4. Brazil castrate-resistant prostate cancer market estimates and forecasts, 2018 - 2030 (USD Million)
5.7.3. Argentina
5.7.3.1. Key country dynamics
5.7.3.2. Regulatory framework
5.7.3.3. Competitive insights
5.7.3.4. Argentina castrate-resistant prostate cancer market estimates and forecasts, 2018 - 2030 (USD Million)
5.8. Middle East & Africa
5.8.1. Middle East & Africa castrate-resistant prostate cancer market estimates and forecasts, 2018 - 2030 (USD Million)
5.8.2. South Africa
5.8.2.1. Key country dynamics
5.8.2.2. Regulatory framework
5.8.2.3. Competitive insights
5.8.2.4. South Africa castrate-resistant prostate cancer market estimates and forecasts, 2018 - 2030 (USD Million)
5.8.3. Saudi Arabia
5.8.3.1. Key country dynamics
5.8.3.2. Regulatory framework
5.8.3.3. Competitive insights
5.8.3.4. Saudi Arabia castrate-resistant prostate cancer market estimates and forecasts, 2018 - 2030 (USD Million)
5.8.4. UAE
5.8.4.1. Key country dynamics
5.8.4.2. Regulatory framework
5.8.4.3. Competitive insights
5.8.4.4. UAE castrate-resistant prostate cancer market estimates and forecasts, 2018 - 2030 (USD Million)
5.8.5. Kuwait
5.8.5.1. Key country dynamics
5.8.5.2. Regulatory framework
5.8.5.3. Competitive insights
5.8.5.4. Kuwait castrate-resistant prostate cancer market estimates and forecasts, 2018 - 2030 (USD Million)
Chapter 6. Competitive Landscape
6.1. Participant Overview
6.2. Company Market Position Analysis
6.3. Company Categorization
6.4. Strategy Mapping
6.5. Company Profiles/Listing
6.5.1. Sanofi
6.5.1.1. Overview
6.5.1.2. Financial performance
6.5.1.3. Material benchmarking
6.5.1.4. Strategic initiatives
6.5.2. Johnson & Johnson Services, Inc.
6.5.2.1. Overview
6.5.2.2. Financial performance
6.5.2.3. Material benchmarking
6.5.2.4. Strategic initiatives
6.5.3. Pfizer, Inc.
6.5.3.1. Overview
6.5.3.2. Financial performance
6.5.3.3. Material benchmarking
6.5.3.4. Strategic initiatives
6.5.4. Astellas Pharma, Inc.
6.5.4.1. Overview
6.5.4.2. Financial performance
6.5.4.3. Material benchmarking
6.5.4.4. Strategic initiatives
6.5.5. Bayer AG
6.5.5.1. Overview
6.5.5.2. Financial performance
6.5.5.3. Material benchmarking
6.5.5.4. Strategic initiatives

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings